Corient Private Wealth
HAE icon

Corient Private Wealth’s Haemonetics HAE Stock Holding History

Corient Private Wealth’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Buy
+29,304
New +$1.91M ﹤0.01% 1366
2025
Q4 		– Sell
-5,861
Closed -$286K – 2759
2025
Q3 		$286K Buy
5,861
+628
+12% +$38.9K ﹤0.01% 2151
2025
Q2 		$390K Buy
5,233
+600
+13% +$39.7K ﹤0.01% 1834
2025
Q1 		$294K Sell
4,633
-32
-0.7% -$2.18K ﹤0.01% 1863
2024
Q4 		$364K Buy
4,665
+37
+0.8% +$2.97K ﹤0.01% 1793
2024
Q3 		$372K Sell
4,628
-210
-4% -$17K ﹤0.01% 1907
2024
Q2 		$400K Sell
4,838
-7
-0.1% -$616 ﹤0.01% 1761
2024
Q1 		$414K Buy
4,845
+28
+0.6% +$2.2K ﹤0.01% 1723
2023
Q4 		$412K Buy
4,817
+232
+5% +$20.1K ﹤0.01% 1707
2023
Q3 		$411K Buy
4,585
+14
+0.3% +$1.25K ﹤0.01% 1591
2023
Q2 		$389K Hold
4,571
– – ﹤0.01% 1583
2023
Q1 		$378K Buy
+4,571
New +$370K ﹤0.01% 1494

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Corient Private Wealth's HAE Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Haemonetics (HAE) in Q1 2026: 29,304 shares worth $1.65M. The stake represents ﹤0.01% of the portfolio and ranks #1366 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in HAE as recently as Q3 2025.

Corient Private Wealth first reported a position in HAE in Q1 2023 and has held it in 12 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Corient Private Wealth held 29,304 shares of Haemonetics worth $1.65M as of Q1 2026.
  • Haemonetics was a new Corient Private Wealth position in Q1 2026.
  • Haemonetics made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1366 holding.
  • Corient Private Wealth first reported a position in Haemonetics in Q1 2023 and has held it in 12 quarters since.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.